title: Degree of corneal anesthesia after topical application of 0.4% oxybuprocaine ophthalmic solution in normal equids.
abstract: Oxybuprocaine hydrochloride ophthalmic solution has been widely used off-label in horses and donkeys, despite lack of data demonstrating efficacy and safety in these species. The objective of this study was to assess anesthetic efficacy of 0.4% oxybuprocaine hydrochloride ophthalmic solution in horses (n= 5) and donkeys (n= 24) and compare the effects with 0.5% proparacaine hydrochloride ophthalmic solution. The baseline corneal touch threshold (CTT) was measured with a Cochet-Bonnet esthesiometer. Donkeys (n= 12) and horses (n= 5) in group A received sterile ophthalmic solutions 0.4% oxybuprocaine with fluorescein (also termed benoxinate with fluorescein, abbreviated as ben + flu) instilled in one eye and 0.9% sterile sodium chloride solution (NaCl) with fluorescein (Na + flu) in the contralateral eye. Donkeys (n= 12) and horses (n= 5) in group B received sterile ophthalmic solutions (ben + flu) in one eye and 0.5% proparacaine with fluorescein (prop + flu) in the contralateral eye. The CTT was measured at 1 and 5 min post-application and at 5-minute intervals until 75 min after treatment. The CTT changes over time differed significantly between oxybuprocaine-treated and control eyes (P< 0.001). The CTT continued to decrease throughout the duration of the study when compared with baseline values. No statistically significant difference in onset, depth, or duration of corneal anesthesia was found between oxybuprocaine and proparacaine treated eyes during the time of the study. Interestingly, horses were shown to have a significantly more sensitive cornea than donkeys (P= 0.002). Oxybuprocaine and proparacaine reduced corneal sensitivity in donkeys and horses. No local irritation was observed with 0.4% oxybuprocaine.
authors.affiliation: Clinical Sciences, Ross University School of Veterinary Medicine, Saint Kitts and Nevis, West Indies NJ 08830.
authors.forename: Erika
authors.initials: E
authors.lastname: Little
authors.affiliation: Clinical Sciences, Ross University School of Veterinary Medicine, Saint Kitts and Nevis, West Indies NJ 08830.
authors.forename: Kathy
authors.initials: K
authors.lastname: Yvorchuk-St Jean
authors.affiliation: Clinical Sciences, Ross University School of Veterinary Medicine, Saint Kitts and Nevis, West Indies NJ 08830.
authors.forename: William
authors.initials: W
authors.lastname: Little
authors.affiliation: Clinical Sciences, Ross University School of Veterinary Medicine, Saint Kitts and Nevis, West Indies NJ 08830.
authors.forename: Fortune
authors.initials: F
authors.lastname: Sithole
authors.affiliation: Clinical Sciences, Ross University School of Veterinary Medicine, Saint Kitts and Nevis, West Indies NJ 08830.
authors.forename: Guy
authors.initials: G
authors.lastname: St Jean
mesh_terms: D000287:Administration, Topical; D000772:Anesthesia, Local / Q000662:veterinary*; D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D003315:Cornea / Q000187:drug effects*; D018397:Equidae; D008297:Male; D011312:Pressure; D011343:Procaine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology
chemical_list: D000779:Anesthetics, Local; D011343:Procaine; C005298:benoxinate